Recent news on Heparin

FDA Approves Enoxaparin for STEMI  -  25 May 2007
Medscape (subscription)Participants were randomized to receive enoxaparin (a low-molecular-weight heparin) throughout the index hospitalization or weight-based unfractionated

Emisphere Announces Initiation Of Phase III Clinical Program Of ...  -  25 May 2007
Medical News Today (press release),Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone

Differential ErbB1 Signaling in Squamous Cell versus Basal Cell ...  -  25 May 2007
Am J Pathology (subscription)In addition, three ErbB1 ligand transcripts (amphiregulin, heparin-binding epidermal growth factor-like growth factor, and transforming growth factor-) were

Bivalirudin as Effective as Heparin in Acute Coronary Syndromes ...  -  May 14, 2007
DG NewsTo evaluate cardiac outcomes with bivalirudin versus heparin in patients with acute coronary syndromes (ACS), including patients undergoing percutaneous

Low Molecular Weight Heparin Reduces Re-Infarction Rates After MI ...  -  May 11, 2007
DG NewsORLANDO, FL -- May 11, 2007 -- A meta-analysis of 7 randomised controlled trials indicates that low-molecular-weight heparin (LMWH) may be superior to

FDA Approves Lovenox® (Enoxaparin Sodium Injection) For The Most ...  -  May 20, 2007
Medical News Today (press release),Lovenox® is a unique chemical entity in a class of antithrombotic agents known as lowmolecular weight heparin (LMWH). The number one selling low-molecular

FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for ...  -  May 3, 2007
PipelineReview.com (press release),FRAGMIN is the first low-molecular- weight heparin (LMWH) approved in the US for the extended treatment of recurrent VTE in patients with cancer.

FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for ...  -  May 2, 2007
PR-Inside.com (Pressemitteilung),..."Physicians now have an FDA- approved low-molecular-weight heparin specifically for extended treatment to reduce the recurrence of blood clots in patients

New Marketing and Manufacturing Partner Appointed for Synthetic ...  -  Apr 25, 2007
PR Newswire (press release),Alchemia has granted Dr Reddy's the exclusive rights to market its synthetic heparin in North America, with first right of refusal to market the product in

Lovenox For The Most Severe Type Of Heart Attack Treatment ...  -  May 18, 2007
eMaxHealth.com,Lovenox is an antithrombotic agent known as low-molecular weight heparin (LMWH). The number one selling low-molecular weight heparin in the world,

Sanofi-Aventis gets OK in USA for expanded use of Lovenox  -  May 21, 2007
Pharma Times (subscription),...treated with fibrinolysis, enoxaparin significantly reduced the rate of death or recurrent infarction at 30 days by 17% versus unfractionated heparin.

FDA Approves Lovenox(R) (enoxaparin Sodium Injection) For The Most ...  -  May 19, 2007
Medical News Today (press release),Lovenox(R) is an antithrombotic agent known as low-molecular weight heparin (LMWH). The number one selling low-molecular weight heparin in the world,

Report On Kidney Cancer Symposium - New Medical Approaches  -  May 13, 2007
Medical News Today (press release),Dr. Tsimafeyeu presented randomized phase II data on the use of low molecular weight heparin in combination with subcutaneous IL-2. Based on the observation

Blood clots kill 25000 a year  -  May 17, 2007
Telegraph.co.uk,The main medicine used is known as low molecular weight heparin. The authors of the BMJ article added: "The health select committee's report two years ago

Sanofi-Aventis gets new OK for Lovenox  -  May 18, 2007
BusinessWeek...that Lovenox significantly reduced recurring heart attacks or death compared with the standard blood thinner heparin in patients with the condition.

Very Elderly Patients With Acute Coronary Syndrome Benefit From ...  -  Apr 25, 2007
Medscape (subscription)...*Therapies considered included short-term aspirin, short-term heparin, short-term clopidogrel, and catheterization within 48 hours with or without the use

Rapid-Inflation Intermittent Pneumatic Compression for Prevention ...  -  May 1, 2007
Journal of Bone and Joint Surgery (subscription)Nine hundred and two patients were managed with low-molecular-weight heparin alone, and 901 were managed with low-molecular-weight heparin and intermittent

Drug trial brings hope after multiple miscarriages  -  Apr 29, 2007
New Zealand Herald,Five weeks into her pregnancy, she started the daily regime of a low-dose aspirin and a nightly heparin injection. "At first I was so nervous I was scared

FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most ...  -  May 17, 2007
Juraforum.de,Lovenox(R) is a unique chemical entity in a class ofantithrombotic agents known as low-molecular weight heparin (LMWH).The number one selling low-molecular

Alchemia's cancer drug passes hurdle  -  Apr 25, 2007
Sydney Morning Herald,..."The prospect of near-term revenues from heparin and the potential to expand the clinical development portfolio in oncology following the startling Phase II

Analysis: Statins cut stroke risk fast  -  May 2, 2007
Science Daily (press release)Analysis: 'New' heparin stops clots (February 9, 2007) -- Doctors said Friday that low-molecular-weight heparin is superior to regular unfractionated

PolyMedix, Inc. Announces Filing of Registration Statement in ...  -  May 9, 2007
Genetic Engineering News (press release),Using its proprietary computational drug design technology, PolyMedix has created novel antibiotic and anticoagulant antagonist (Heparin and Low Molecular

Momenta starts drug ...  -  May 14, 2007
Boston Globe,The anti-coagulant is M118, which the company describes as heparin drug that has been engineered through Momenta's proprietary technology to provied

Public healthcare suffers from a procurement process full of holes  -  May 21, 2007
Livemint,Dr AK Bisoi, a cardiac surgeon at AIIMS, says that while carrying out valve-replacement surgeries, the same dosage of a blood-thinning drug such as Heparin

Study: Heart attack deaths drop sharply  -  May 2, 2007
San Francisco Chronicle,IIb/IIIa inhibitors; blood thinners such as clopidogrel and low-molecular-weight heparin; and blood pressure-reducing drugs such as ACE inhibitors.

Report: Heart attack death rate in hospitals cut nearly in half  -  May 1, 2007
Boston Globe,...blood thinners such as clopidogrel and low-molecular-weight heparin; and blood pressure-reducing drugs such as angiotensin-converting enzyme, or ACE,

Coronary artery bypass graft surgery—care globalization: The ...  -  May 2, 2007
The Journal of Thoracic and Cardiovascular Surgery...intraoperative transfusion of fresh-frozen plasma or platelets, lack of use of early postoperative aspirin, and use of postoperative heparin.

Care of Heart Patients Showing Strides  -  May 2, 2007
International News Service,IIb/IIIa inhibitors, blood thinners such as clopidogrel and low-molecular- weight heparin, and blood pressure-reducing drugs such as ACE inhibitors.

Study: Full-court press on heart attacks working  -  May 2, 2007
AZ Central.com,IIb/IIIa inhibitors; blood thinners such as clopidogrel and low-molecular-weight heparin; and blood-pressure-reducing drugs such as ACE inhibitors.

Alchemia to hasten cancer drug trial  -  Apr 25, 2007
Sydney Morning Herald,Dr Reddy's now has exclusive rights to market synthetic heparin in North America and has the first right of refusal to market the product in the European

Babies born under miscarriage study  -  Apr 29, 2007
TVNZ,The women take low dose aspirin and the anti-clotting agent heparin until their last month of pregnancy. The two drugs individually help with conditions

New mktg, mfg partner appointed for synthetic heparin  -  26 Apr 2007
Moneycontrol.com,Alchemia has granted Dr Reddy’s the exclusive rights to market its synthetic heparin in North America, with first right of refusal to market the product in

Over 90 less likely to get cardiac treatment  -  26 Apr 2007
United Press InternationalTherapies recommended by American College of Cardiology/American Heart Association guidelines include aspirin; heparin, a blood thinner, and beta blockers,

Lovenox Better Than Unfractionated Heparin For Acute Ischemic ...  -  Apr 23, 2007
eMaxHealth.com,In conclusion the authors said that "enoxaparin is preferable to unfractionated heparin for venous thromboembolism prophylaxis in this high- risk medically

Lovenox Better Than Unfractionated Heparin For Acute Ischemic ...  -  Apr 23, 2007
eMaxHealth.com,Adam Sachs speaks with frequent travelers-including Daily Show regular John Hodgman-who collect over-the-counter European medications like souvenirs.

Enoxaparin Outdoes Heparin for Post-Stroke Venous Thromboembolism  -  Apr 20, 2007
MedPage Today,Venous thrombembolism with either low-molecular-weight heparin or unfractionated heparin is recommended for acute ischemic stroke, but because large studies

Newer Form of Heparin Better at Preventing Clots After Stroke  -  Apr 20, 2007
CBC News,THURSDAY, April 19 (HealthDay News) - A newly engineered form of the blood-thinning drug heparin has proven more effective at preventing life-threatening

PREVAIL: Enoxaparin bests heparin for VTE prophylaxis poststroke  -  Apr 20, 2007
TheHeart.Org,..."Enoxaparin is preferable to unfractionated heparin for venous thromboembolism prophylaxis in this high-risk medically ill population, in view of its better

Stopping Fatal Blood Clots After Acute Ischaemic Stroke  -  Apr 20, 2007
Medical News Today (press release),Enoxaparin is more effective than unfractionated heparin at stopping fatal blood clots in the veins of the legs and lungs following an acute ischaemic

A Better Blood Thinner  -  Apr 20, 2007
WFIE-TV,According to investigators who compared the two drugs -- enoxaparin and unfractionated heparin -- enoxaparin was 43-percent more effective at preventing

The Lancet Publishes PREVAIL Study Results  -  Apr 20, 2007
Newsdesk,Enoxaparin is an anticoagulant of the low molecular weight heparin (LMWH) class. Its clinical. applications are linked to its antithrombotic properties.

Sanofi blood thinner better than older drug: study  -  Apr 19, 2007
Scientific AmericanResearchers compared Sanofi's Lovenox, a once-daily injection known generically as enoxaparin, with unfractionated heparin, a cheaper, twice-daily treatment

Sanofi-aventis (SNY) Says Published Report has PREVAIL Study ...  -  Apr 20, 2007
StreetInsider.com (subscription),The results of the trial showed that once daily administration of Clexane / Lovenox 40 mg was more effective than UnFractionated Heparin (UFH) 5000 IU twice

Market Report -- In Play (SNY)  -  Apr 20, 2007
MSN MoneySanofi-Aventis: Prevail study results showing Lovenox superiority over unfractionated Heparin for reducing risk of venous thromboembolism Co announces the

It's up to you to read the label on prescriptions  -  Apr 14, 2007
Rio Rancho Observer,Apparently, my immune system was wildly releasing histamine and heparin. Histamine is an antibody meant to neutralize bacteria and viruses.

Action plan on deadly blood clots  -  Apr 19, 2007
BBC News,But the clots are easy to prevent using simple measures, such as blood-thinning drugs like heparin and surgical stockings.

Enzyme Might Fight Nasopharyngeal Cancer  -  Apr 18, 2007
Post ChronicleThe enzyme -- SULF2 -- is a heparin-degrading endosulfatase that appears to be significantly overexpressed in nasopharyngeal cancers.

The Cost-Effectiveness of Extended-Duration Antithrombotic ...  -  Apr 2, 2007
Journal of Bone and Joint Surgery (subscription)The net treatment costs per 1000 patients treated were $799104 with low-molecular-weight heparin and $72236 with warfarin. In comparison with the cohort

Cheney's Blood Clot Improving  -  Apr 25, 2007
Medical News Today,The most common treatment of DVT is to give the patient anticoagulants or blood thinners, usually a short course of heparin followed by a longer course of

Exploring Therapies for Acute Coronary Syndromes: IIb/IIIa ...  -  Apr 10, 2007
TheHeart.Org,...of thrombolytic agents, aspirin, thienopyridines, GP IIb/IIIa inhibitors, unfractionated heparin (UFH), and/or a low-molecular weight heparin (LMWH).

Deal in a Durham deli may lead to a blood thinner worth $1 billion ...  -  Mar 28, 2007
News & Observer,A blood thinner called heparin has been used for heart patients for about 50 years. The drug prevents the blood from clotting and allows the use of

GlaxoSmithKline: Results Announcement for the First Quarter 2007  -  Apr 25, 2007
PharmaLive.com (press release),Arixtra is the first new anti-thrombotic agent to be approved in Japan for VTE since the approval of unfractionated heparin in 1972.

Nurse to face hearing as bid to stop case is rejected  -  Apr 4, 2007
Hemelhempstead Today,She is also accused of giving another patient too much of the anti-blood clotting drug heparin, when she was working at the Hemel Hempstead Hospital.

Corrected: New clot drugs beckon as replacements for warfarin  -  Apr 16, 2007
Scientific AmericanThe oral drugs could prove better and safer than injectable medicines such as heparin now widely used to cut the risk of dangerous blood clots in the legs

Medicure's Aggrastatr Highlighted in Expert Opinion Journal  -  Apr 20, 2007
PharmaLive.com (press release),AGGRASTATR, in combination with heparin, is indicated for the treatment of acute coronary syndrome, including patients who are to be medically managed and

Medicure's AGGRASTAT(R) Highlighted in Expert Opinion Journal  -  Apr 20, 2007
SYS-CON Media,AGGRASTAT®, in combination with heparin, is indicated for the treatment of acute coronary syndrome, including patients who are to be medically managed and

Medicure's AGGRASTAT(R) Highlighted in Expert Opinion Journal  -  Apr 20, 2007
CCNMatthews (press release),AGGRASTAT ® , in combination with heparin, is indicated for the treatment of acute coronary syndrome, including patients who are to be medically managed and

Medicure's AGGRASTAT(R) Highlighted in Expert Opinion Journal  -  Apr 20, 2007
Genetic Engineering News (press release),AGGRASTAT(R), in combination with heparin, is indicated for the treatment of acute coronary syndrome, including patients who are to be medically managed and

Elder Pharma records 19.55% topline growth  -  Apr 24, 2007
Moneycontrol.com,...tie-up and HIBOR an anti-thrombotic low molecular weight heparin has been launched through a tie-up with Laboratorios Farmaceuticos ROVI sa of Spain.

New Guidelines for Treatment of Acute Ischemic Stroke  -  Apr 19, 2007
Medscape (subscription)During hospitalization, stroke patients should receive a swallowing evaluation as well as prophylaxis against deep venous thrombosis with heparin or

Studies Highlight Advances In Diagnosis, Medical Therapy And ...  -  Apr 1, 2007
Medical News Today (press release),At one year, death occurred in 4.4 percent of patients treated with heparin plus GPI, 4.2 percent of patients treated with bivalirudin plus GPI,

Primary Percutaneous Coronary Intervention  -  Apr 11, 2007
New England Journal of Medicine (subscription),3 Finally, because of possible adverse effects on the clinical outcome, the risk of thrombocytopenia induced by treatment with heparin or glycoprotein

Drug Test Cowboys: The Secret World of Pharmaceutical Trial Subjects  -  Apr 23, 2007
Wired NewsA blood- tapping device called a heparin lock protrudes from a vein in my arm, and electrodes are attached to 10 freshly shaved spots on my chest.

Arbios Systems Reports Favorable Results From the SEPET(TM ...  -  Apr 5, 2007
Drug Newswire (press release),FDA has recently allowed discretionary substitution of an alternative anticoagulation method, utilizing sodium citrate instead of heparin, meant to reduce

'Angiox' Licensed For Use In PCI, As Effective As More Complicated ...  -  Apr 2, 2007
Medical News Today (press release),Heparin plus a GPI is often used as part of these treatments to reduce the risk of blood clotting and further ischemia. However, while heparin plus GPI can

GlaxoSmithKline Receives Japanese Approval For Two Major New ...  -  Apr 23, 2007
Medical News Today (press release),...in February 2006 and is the first anti-thrombotic agent to be approved for the prevention of VTE since the approval of unfractionated heparin in 1972.

Prognostic Enzyme For Nasopharyngeal Cancer Identified  -  Apr 22, 2007
Medical News Today (press release),SULF2, a recently identified heparin-degrading endosulfatase, appears to be significantly overexpressed in nasopharyngeal cancers, providing hope of the

Freeze, i’m not dead  -  Apr 21, 2007
Malaysia Star,If dead, push 40000 international units heparin intravenous (an anti-blood clotting agent) and do cardio-pulmonary resuscitation while cooling with ice.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional